Why the study?
Does aerosolized ribavirin and related compounds improve outcomes in mice and primates with influenza infections?
Population
Mice and primates (squirrel monkeys) with influenza virus infections
Design
Preclinical
Authors
Loading...
Aerosolized ribavirin shows preclinical activity in influenza models; leaves open translation to human efficacy and safety trials.
Does aerosolized ribavirin and related compounds improve outcomes in mice and primates with influenza infections?
Aerosolized ribavirin demonstrates significant therapeutic potential for treating influenza infections in preclinical models.
Stephen et al. (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: